Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.24.3
Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 4,703 $ 4,928
Prepaid expenses and other current assets 476 450
Total current assets 5,179 5,378
Total Assets 5,179 5,378
Current Liabilities:    
Accounts payable and accrued expenses 15,635 15,485
Accounts payable and accrued expenses - related party 2,009 2,815
Common stock warrant liabilities 125 125
Total current liabilities 17,769 18,425
Total Liabilities 17,769 18,425
Commitments and Contingencies (Note 5)
Stockholders' Equity (Deficit)    
Common stock issuable, 0 and 1,492,915 shares as of September 30, 2024 and December 31, 2023, respectively   3,419
Additional paid-in capital 329,078 297,864
Accumulated deficit (341,673) (314,333)
Total Stockholders' Equity (Deficit) (12,590) (13,047)
Total Liabilities and Stockholders' Equity (Deficit) 5,179 5,378
Common No Class    
Stockholders' Equity (Deficit)    
Common Stock Value $ 5 $ 3